Target cell-induced apoptosis in IL-2-activated human natural killer cells

Leukemia and Lymphoma

Volumn 32, Issue 5-6, 1999, Pages 451-458

  Taga, K ^a,b   Yamauchi, Akira ^a,c   Bloom, E T ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b Neagari Hospital   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; IL 2 activated; Natural killer cells; NK cells; Target cell induced apoptosis

Indexed keywords

FAS ANTIGEN; INTEGRIN; INTERLEUKIN 2; PROTEIN KINASE P60; PROTEINASE;

APOPTOSIS; ARTICLE; LYMPHOKINE ACTIVATED KILLER CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TARGET CELL; TUMOR CELL;

EID: 0032977392     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909058402     Document Type: Article

References (49)

1. Ullberg, G. and Jondal, M. (1981) Recycling and target binding capacity of human natural killer cells. J. Exp. Med., 153, 615-628.
2. Windebank, K.P., Abraham, R.T., Powis, G., Olsen, R.A., Barna, T.J. and Leibson, P.J. (1988) Signal transduction during human natural killer cell activation: Inositol phosphate generation and regulation by cyclic AMP. J. Immunol., 141, 3951-3957.
3. Melero, I., Salmeron, S., Balboa, M.A., Aramburu, J. and Lopez-Botet , M. (1994) Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes. J. Immunol., 152, 1662-1673.
4. Arroyo, A.G., Campanero, M.R., Sanchez-Mateos, P., Zapata, J.M., Ursa, A., del Pozo, M.A. and Sanchez-Madrid, F. (1994) Induction of tyrosine phosphorylation during ICAM-3 and LFA-1-mediated intercellular adhesion, and its regulation by CD45 tyrosine phosphatase. J. Cell Biol., 126, 1277-1286.
5. Sugie, K., Minami, Y., Kawakami, T. and Uchida, A. (1995) Stimulation of NK-like YT cells via leukocyte function-associated antigen (LFA)-1. Possible involvement of LFA-1-associated tyrosine kinase in signal transduction after recognition ofNK target cells. J. Immunol., 154, 1691-1698.
6. Umehara, H., Takashima, A., Minami, Y. and Bloom, E.T. (1993) Signal transduction via phosphorylated adhesion molecule. LFA-1b (CDI8), is increased by culture of natural killer (NK) cells with interleukin (IL)-2 in the generation of lymphokine activated killer (LAK) cells. Int. Immunol., 5, 19-27.
7. Damle, N.K., Klussman, K., Leytze, G., Aruffo, A., Linsly, P.S. and Ledbetter, J.A. (1993) Costimulation with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 augment activation-induced death of antigen-specific CD4+ T lymphocytes. J. Immunol., 151, 2368-2379.
8. Ortaldo, J.R., Mason, A.T. and O'Shea J.J. (1995) Receptor-induced death in human natural killer cells: involvement of CD16. J. Exp. Med., 181, 339-344.
9. Taga, K., Yamauchi, A., Kabashima, K., Bloom, E.T., Muller, J. and Tosato, G. (1996) Target-induced death by apoptosis in human lymphokine-activated natural killer cells. Blood, 87, 2411-2418.
10. Yamauchi, A., Taga, K., Mostowski, H.S. and Bloom, E.T. (1996) Target cell-induced apoptosis of interleukin-2-activated human natural killer cells: roles of cell surface molecules and intracellular events. Blood, 12, 5127-5135.
11. O'Connell, J., O'Sullivan, G.C., Collins, J.K. and Shanahan, F. (1996) The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing as ligand. J. Exp. Med., 184, 1075-1082.
12. Niehans, G.A., Brunner, T., Frizelle, S.P., Liston, J.C., Salerno, C.T., Knapp, D.J., Green, D.R. and Ktatzke, R.A. (1997) Human lung carcinomas express Fas ligand. Cancer Res., 57, 1007-1012.
13. Strand, S., Hofmann, W.J., Hug, H., Muller, M., Otto, G., Strand, D., Mariani, S.M., Stremmel, W., Krammer, P.H. and Galle, R.R. (1996) Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion. Nature Med., 2, 1361-1366.
14. Baume, D.M., Robertson, M.J., Levine, H., Manley, T.J., Schow, P.W. and Ritz, J. (1992) Differntial responses to interleukin 2 define functionally district subsets of human natural killer cells. Eur. J. Immunol., 22, 1-6.
15. Surh, C.D. and Sprent, J. (1994) T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature, 372, 100-103.
16. Nagata, S. and Golstein, P. (1995) The Fas death factor. Science, 267, 1449-1456.
17. Wesselborg, S., Janssen, O. and Kabellitz, D. (1993) Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J. Immunol., 150, 4338-4345.
18. Radvanyi, L.G., Mills, G.B. and Miller, R. G. (1993) Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death. J. Immunol., 150, 5704-5715.
19. Mogil, R.J., Shi, Y., Bissonnette, R.P., Bromley, P., Yamaguchi, I. and Green, D.R. (1994) Role of DNA fragmentation in T cell activation-induced apoptosis in vitro and in vivo. J. Immunol., 152, 1674-1683.
20. Orchansky, P.L. and Teh, H-S. (1994) Activation-induced cell death in proliferating T cells is associated with tyrosine phospholyration of TCR/CD3 subunits. J. Immunol., 153, 615-622.
21. Eischen, C.M., Schilling, J.D., Lynch, D.H., Krammer, P.H. and Leibson, P.J. (1996) Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. J. Immunol., 156, 2693-2699.
22. Novelli, F., Bernabei P., Ozmen L., Rigamonti L., Allione A., Pestka S., Garotta G. and Forni G. (1996) Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-gamma is correlated with the differential expression of the alpha-and beta-chains of its receptor. J. Immunol., 157, 1935-1943.
23. Jewett, A. and Bonavida, B. (1996) Target-induced inactivation and cell death by apoptosis in a subset of human NK cells. J. Immunol., 156, 907-915.
24. Robertson, M.J., Caliggiuri, M.A., Manley, T.J., Levine, H. and Ritz, J. (1990) Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis, J. Immunol., 145, 3194-3210.
25. Patarroyo, M., Prieto, J., Rincon, J., Timonen, T., Lundberg, C., Lindbom, L., Asjo, B. and Gahmberg. C.G. (1990) A molecular process fundamental in leukocyte physiology, Immunol. Rev., 114, 67-108.
26. Maenpaa, A., Jaaskellainen, J., Carpen, O., Patarroyo, M. and Timonen, T. (1993) Expression of integrins and other adhesion molecules on NK cells: impact of IL-2 on shortand long-cultures. Int. J. Cancer, 53, 850-855.
27. Melero, I., Balboa, M.A., Alonso, J.L., Yague, E., Pivel, J.P., Sanchez-Madrid, F. and Lopez-Botet, M. (1993) Signaling through the LFA-1 leukocyte integrin actively regulates intercellular adhesion and tumor necrosis factor-production in natural killer cells. Eur. J. lmmunol., 23, 1859-1865.
28. Vyth-Dreese, F.A., Dellemijn, T.A.M., Frijhoff, A., van Kooyk, Y. and Figdor, C.G. (1993) Role of LFA-1/ICAM-1 in interleukin-2-stimulated lymphocyte proliferation. Eur. J. Immunol., 23, 3292-3299.
29. Chong, S.S.-F., Boussy, I.A., Jiang, X., Lamas, M. and Graf, L.H.Jr. CD54/ICAM-1 is a costimulator of NK cell-mediated cytotoxicity. Cell. Immunol., 157, 92-105.
30. Ozone, L., Anegon, I., Calaabretta, B. and Perussia, B. (1995) Ligand binding to FcγR induce c-myc-denendent apoptosis in IL-2-stimulated NK cells. J. Immunol., 154, 491-499.
31. Azuma, M., Cayabyab, M., Buck, D., Phillips, J.H. and Lanier L.L. (1992) Involvement of CD28 in MHC-unristricted cytotoxicity mediated by a human natural killer leukemia cell line. J. Immunol., 149, 1115-1123.
32. Azuma, M., Yssel, H., Phillips, J.H. and Spits, H. (1993) Functional expression of B7/BB1 on activated T lymphocytes. J. Exp. Med., 177, 845-850.
33. Yeh, K-Y., Pulaski, B.A., Woods, M.L., McAdam, A.J., Gaspari, A.A., Frelinger, J. G. and Lord, E.M. (1995) B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma. Cell, Immunol., 165, 217-224.
34. Cleveland, J.L. and Ihle J.N. (1995) Contenders in Fas-L/TNF death signaling. Cell, 81, 479-482.
35. Crispe, I.N. (1994) Fatal iterations: Fas-induced apoptosis of mature T cells. Immunity, 1, 347-349.
36. Nagata, S. (1994) Fas and Fas ligand: A death factor and its receptor. Adv. Immunol., 57, 129-144.
37. 2/M phase. Nucleic Acids Res., 20, 2607.
38. Williams, M.S., and Henkart (1994) Apoptotic cell death induced by intracellular proteolysis. J. Immunol., 153, 4247-4255.
39. Sarin, A., Clerici, M., Blatt, S.P., Hendrix, C.W., Shearer, G.M. and Henkart, P.A. (1994) Inhibition of activation-induced programmed cell death and restoration of defective immune responses of HIV+ donor by cysteine protease inhibitors. J. Immunol., 153, 862-872.
40. Sarin, A., Adams, D.H. and Henkart, P.A. (1993) Protease inhibitors selectively block T cell hybridoma and activated peripheral T cells. J. Exp. Med., 178, 1693-1700.
41. Su, B., Bochan, M.R., Hanna, W. L., Froelich, C.J. and Brahmi, Z. (1994) Human granzyme B is essential for DNA fragmentation of susceptible target cells. Eur. J. Immunol., 24, 2073-2080.
42. Rabinowich, H., Lin, W-c., Manciulea, M., Herberman, R.B. and Whiteside, T.L. (1995) Induction of protein kinase phosphorylation in human natural killer cells by triggering via α4β1 α5β1 integrins. Blood, 85, 1858-1864.
43. Shi, L., Kam, C-M., Powers, J.C., Aebersold, R. and Greenberg, A.H. (1992) Purification of three cytotoxic lymphocyte granule serine proteases that induced apoptosis through direct substrate and target cell interactions. J. Exp. Med., 176, 1521-1529.
44. Nakajima, H., and Henkart, P.A., (1994) Cytotoxic lymphocyte granzymes trigger a target cell internal disintegration pathway leading to cytolysis and DNA breakdown. J. Immunol., 152, 1057-1063.
45. Heusel, J.W., Wesselschmidt, R.L., Shresta, S., Russel, J.H. and Ley, T.J. (1994) Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell, 76, 977-987.
46. Trinchieri G (1989), Biology of natural killer cells. Adv. Immunol. 47: 187-376.
47. Tartour, E., Mathiot, C. and Fridman, W.H. (1992) Current status interleukin-2 therapy in cancer. Biomed. & Pharmacother., 46, 473-484.
48. Sprano, J.A., Fisher, R.I., Sunderland, M., Margolin, K., Ernest, M.L., Sznol, M., Atkins, M.B., Dutcher, J.P., Micetich, K.C. and Weiss, G.R. (1993) Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with Interferon alpha 2a in patients with advanced melanoma. J. Clin. Oncol., 11, 1969-1977.
49. Rosenberg, S.A., Yang, J.C., Topalian, S.L., Schwarzentruber, D.J., Weber, D.R., Parkinson, C.A., Seipp, C.A., Einhorn, J.H. and White, D.E. (1994) Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high dose bolus interleukin-2. JAMA, 271, 907-913.